Bariatric Surgery Shown to Induce Wide-Ranging Metabolic Changes: New PET Imaging Insights

Recent findings presented at the Society of Nuclear Medicine and Molecular Imaging's 2026 Annual Meeting have highlighted the systemic metabolic impacts of bariatric surgery, using novel PET imaging techniques. These insights are expected to enhance the precision of postoperative metabolic monitoring and individualized patient care.

Bariatric surgery, which has been used for over 70 years to facilitate significant weight loss and manage obesity-related conditions, continues to be a chosen intervention for many despite advances in GLP-1 medication therapies. A new retrospective study investigated the broader metabolic effects of such surgeries, including laparoscopic sleeve gastrectomy and one-anastomosis gastric bypass, on patients with obesity.

The study involved 32 patients whose metabolic functions were assessed with whole-body 18F-FDG PET/CT imaging and comprehensive laboratory tests both prior to surgery and one year postoperatively. This evaluation aimed to detect metabolic changes in various tissues, including subcutaneous and visceral fat, liver, pancreas, spleen, adrenal glands, and skeletal muscle. By comparing these findings with those from healthy controls, researchers evaluated the metabolic alterations at an organ level.

The results showcased that post-surgical patients exhibited coordinated metabolic adjustments across numerous organs, encompassing fat tissue, liver, pancreas, muscle, and more. Importantly, these changes correlated with enhancements in glycemic control, lipid profiles, and both endocrine and inflammatory markers. Network analysis further indicated a more synchronized metabolic process between organs following surgery.

"Currently, clinicians do not have a clear way to see how the body's metabolism changes after bariatric surgery," commented Zeyang Wang, MSc, a PhD candidate at the Medical University of Vienna. "Molecular imaging may help show how different organs respond after surgery, beyond what can be measured by weight loss or blood tests alone."

This expansive study supports the utility of whole-body 18F-FDG PET/CT imaging in understanding organ-level metabolic health and underscores its potential in tailoring postoperative care more precisely. By capturing the full scope of metabolic recovery, this approach may offer significant advancements in how clinicians manage and monitor patients post-bariatric surgery.